Although complicated regulatory mechanisms underlie the various ion transporters, we found enhanced expression of Slc26a6 and Cl− transporting activity in the db/db heart, suggesting that effective Slc26a6 blockers may be efficient in modulating pH of type 2 diabetic hearts. Here, SLC26A6 is linked to type 2 diabetes mellitus.